a patient's life, patients with OA are likely to be treated with a number of different pharmaceutical and nonpharmaceutical interventions, often in combination. This report provides recommendations to guide patients and clinicians in choosing among the available treatments. Certain principles of management apply to all patients with OA (see Comprehensive Management of OA below and Figure 1 METHODS This guideline, from the American College of Rheumatology (ACR) and the Arthritis Foundation (AF), follows the ACR guideline development process ( https ://www.rheum https ://www.rheum http://onlin elibr ary. wiley.com/doi/10.1002/art.41142/ abstract Briefly, this work involved 5 teams: 1) a Core Leadership Team that supervised and coordinated the project and drafted the clinical/population, intervention, comparator, outcomes (PICO) questions that served as the basis for the evidence report and manuscript; 2) a Literature Review Team that completed the literature screening and data